(Q28189131)

English

Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit?

scientific article (publication date: 2005)

In more languages

Statements

scholarly article

0 references

Stroke units, tissue plasminogen activator, aspirin and neuroprotection: which stroke intervention could provide the greatest community benefit? (English)

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Amanda G. Thrift

object named as

Amanda G Thrift

2

0 references

Geoffrey A. Donnan

object named as

Geoffrey A Donnan

6

0 references

4

object named as

Helen M Dewey

0 references

Amanda K Gilligan

1

object named as

Amanda K Gilligan

0 references

Jonathan W Sturm

3

object named as

Jonathan W Sturm

0 references

author name string

Richard A L Macdonell

5

0 references

language of work or name

0 references

publication date

2005

0 references

Cerebrovascular Diseases

0 references

20

0 references

4

0 references

239-44

0 references

Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Stroke incidence on the east coast of Australia: the North East Melbourne Stroke Incidence Study (NEMESIS).

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Comparing stroke incidence worldwide: what makes studies comparable?

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Early intravenous thrombolysis for acute ischemic stroke in a community-based approach

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Regional access to acute ischemic stroke intervention.

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Prehospital and in-hospital delays in acute stroke care

1 reference

https://api.crossref.org/works/10.1159%2F000087705

21 January 2018

Identifiers

10.1159/000087705

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28189131&oldid=1743148546"